日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

US EUROPE AFRICA ASIA 中文
Business / Industries

Stem cells offer ray of hope for healthy future

By Alfred Romann in Seoul For China Daily (China Daily) Updated: 2014-06-23 07:08

Regenerative medicine sector needs more financial support from private investors

One of the most important and innovative pharmaceutical companies in Asia has its headquarters in a busy neighborhood of Seoul, nestled between insurance companies and banks, and not far from Seoul National University.

Medipost Co Ltd, launched in 2000 to research and develop stem cell and regenerative medicine products, has emerged as a leader in the space, both regionally and globally. It took a dozen years for the company to launch its first product commercially: Cartistem used to treat repair cartilages in the knee.

Between its founding and its first product launch, Medipost issued new shares six times and split its stock once. It generated some further revenue, mostly by storing umbilical cord blood, using the blood to transplant stem cells, and later by out-licensing products.

But that income was tiny compared to the cost of developing its drugs. Improbably, it managed to attract enough investors to keep going and growing.

That investment is now starting to pay off. Cartistem is just one of three stem cell products approved for sale in South Korea, and Medipost might be the only public company in the country with global ambitions.

"There are not many companies that can deal with global development in the pharmerging market," said Jay Lee, a senior director at Medipost, speaking at a conference in South Korea last month.

The "pharmerging" markets are the emerging markets for pharmaceutical products. China is possibly the biggest, but there are quite a few of them in the region including South Korea and much of the Association of Southeast Asian Nations.

Even Japan, despite its large economy, is considered an emerging market in some ways because it is often years before drugs developed elsewhere make their way down to patients there due to conservative regulations.

But much is changing in the region, particularly in South Korea and Japan. Both countries are embracing often-controversial research into regenerative medicine, including stem cells.

"There is an exceptional example of a new approach in Japan. They are looking very much, as in South Korea, to develop the stem cell space," says Dianne Jackson-Matthews, an Australia-based director at ERA Consulting Group.

For the time being, government support is driving the growth of this particular industry. Private or institutional investors are not yet convinced that taking a risk on a company developing a drug using science few people understand is worthwhile.

Stem cells offer ray of hope for healthy future

Stem cells offer ray of hope for healthy future

 Stem Cell Industrial Park under construction in Wenjiang  Medical experts call for effective stem cell treatment regulation

Previous Page 1 2 3 Next Page

Hot Topics

Editor's Picks
...
...
主站蜘蛛池模板: 狠狠干少妇| 中文字幕高清在线免费播放 | 超碰公开在线 | 国产午夜精品一区二区三区视频 | 亚洲成人看片 | 97中文字幕 | 天天操网站 | 欧美男人天堂 | 精品xxx| 国产第一页在线播放 | 成人在线超碰 | 国产黄色在线播放 | 欧美成人高清在线 | 黄色日韩| 色播五月婷婷 | 成人国产免费 | 久久久久久久久久久影院 | 一区二区网 | 成年人黄色在线观看 | 色婷婷av一区二区 | 麻豆黄色片 | 国产天堂在线观看 | 国产拍拍 | 99精品欧美一区二区三区综合在线 | 牛牛视频在线观看 | 中文字幕在线播放一区 | 波多野结衣家庭教师 | 亚洲免费高清视频 | 伊人久久久久久久久久 | 欧美精品aaa | 女人的天堂网站 | 国产成人福利 | 中文字幕视频在线观看 | 久久久久久久久网站 | 在线看黄色片 | 国产福利资源在线 | 在线观看中文字幕 | 久久综合爱 | √资源天堂中文在线 | 中文在线资源天堂 | 亚洲最大福利视频 |